Cargando…

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging

Detalles Bibliográficos
Autor principal:	Matsuo, Shinro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Cardiology 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281723/ https://www.ncbi.nlm.nih.gov/pubmed/30546502 http://dx.doi.org/10.1016/j.jccase.2014.03.004

Ejemplares similares

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

The Diameter of Retinal Arterioles Is Unaffected by Intravascular Administration of the Adenosine A(2A) Receptor Agonist Regadenoson in Normal Persons
por: Dons-Jensen, Anna, et al.
Publicado: (2019)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison
por: Gibarti, Claudia, et al.
Publicado: (2023)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Transient Ischemic Dilation Ratio in Regadenoson, Single Isotope Gated Single-photon Emission Computed Tomography Myocardial Perfusion Imaging
por: Rubio, Manolo, et al.
Publicado: (2017)

Improved quantification of small hearts for gated myocardial perfusion imaging
por: Nakajima, Kenichi, et al.
Publicado: (2013)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging
por: Hoffmeister, C., et al.
Publicado: (2014)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Inferior Myocardial Infarction Secondary to Coronary Artery Vasospasm Following Regadenoson Stress Imaging
por: Fogelson, Benjamin, et al.
Publicado: (2022)

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
por: DiBella, Edward V. R., et al.
Publicado: (2011)

The Significance of ST Depression in a Postmenopausal Woman on Estrogen Therapy during Regadenoson Myocardial SPECT Imaging
por: Kiran Mehta, Nishaki, et al.
Publicado: (2015)

Significance of New, Isolated T-wave Inversion in Multiple Electrocardiogram Leads with Regadenoson Injection in Patients with Normal Myocardial Perfusion Imaging: An Observational Report of 5 Consecutive Cases
por: Tung, Robert T.
Publicado: (2019)

Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
por: Gill, Gauravpal Singh, et al.
Publicado: (2022)

Regadenoson-Stress Dynamic Myocardial Perfusion Improves Diagnostic Performance of CT Angiography in Assessment of Intermediate Coronary Artery Stenosis in Asymptomatic Patients
por: Baxa, Jan, et al.
Publicado: (2015)

Evaluation of Myocardial Perfusion Imaging SPECT Parameters and Pharmacologic Stress Test with Adenosine Versus Coronary Angiography Findings: Are They Diagnostically Concordant?
por: Hasbek, Zekiye, et al.
Publicado: (2019)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Development of Coronary Vasospasm during Adenosine-Stress Myocardial Perfusion CT Imaging
por: Nam, Jeong Gu, et al.
Publicado: (2015)

Regadenoson as a pharmacologic stressor in cardiac magnetic resonance imaging in congenital and acquired pediatric heart disease: initial experience
por: Noel, Cory V, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_12auh6mhf1n344oi7fpf7vp8go